These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6289105)

  • 1. Cell cloning as a tool to analyze the immune response.
    Paul WE; Sredni B; Howard M
    Natl Cancer Inst Monogr; 1982; 60():211-4. PubMed ID: 6289105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EB virus induction is associated with B-cell maturation.
    Crawford DH; Ando I
    Immunology; 1986 Nov; 59(3):405-9. PubMed ID: 3025081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell maturation factor: effects on various cell populations.
    Sidman CL; Marshall JD
    J Immunol; 1984 Feb; 132(2):845-50. PubMed ID: 6418813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukins for B lymphocytes.
    Howard M; Paul WE
    Lymphokine Res; 1982; 1(1):1-4. PubMed ID: 6985399
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-specific factor enhancement of human in vitro antigen-dependent antibody synthesis: role of B cell activation and T cell help.
    Brenner MK; North ME; Chadda HR; Farrant J
    Immunology; 1984 Apr; 51(4):783-91. PubMed ID: 6608488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of functional human T lymphocytes by limiting dilution: impact of filler cells and interleukin 2 sources on cloning efficiencies.
    Kahle P; Wernet P; Rehbein A; Kumbier I; Pawelec G
    Scand J Immunol; 1981 Nov; 14(5):493-502. PubMed ID: 6278580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of anti-endothelial cell antibodies by coculture of EBV-infected human B cells with endothelial cells.
    Delneste Y; Lassalle P; Jeannin P; Mannessier L; Dessaint JP; Joseph M; Tonnel AB
    Cell Immunol; 1993 Aug; 150(1):15-26. PubMed ID: 7688268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term culture and cloning of nontransformed human B lymphocytes.
    Sredni B; Sieckmann DG; Kumagai S; House S; Green I; Paul WE
    J Exp Med; 1981 Nov; 154(5):1500-16. PubMed ID: 6975349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
    Burgstahler R; Kempkes B; Steube K; Lipp M
    Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signals in B lymphocyte proliferation and differentiation.
    Schimpl A
    Ann Immunol (Paris); 1983; 134D(1):143-53. PubMed ID: 6354067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD; Stewart JP; Arrand JR; Mackett M
    Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
    Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
    Stein LD; Ledgley CJ; Sigal NH
    J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation.
    Falkoff RJ; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1984 Aug; 133(2):692-6. PubMed ID: 6610708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of virus-specific memory B cells in the absence of T cell help.
    Hebeis BJ; Klenovsek K; Rohwer P; Ritter U; Schneider A; Mach M; Winkler TH
    J Exp Med; 2004 Feb; 199(4):593-602. PubMed ID: 14769849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.